New patent expiration for Celgene drug THALOMID

Annual Drug Patent Expirations for THALOMID Thalomid is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are nine patents protecting…

The post New patent expiration for Celgene drug THALOMID appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog